25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

被引：3

作者：

Michos, Erin D. ^{[1
]}

Lutsey, Pamela L. ^{[2
]}

机构：

[1] Johns Hopkins Univ, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21287 USA

[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA

来源：

ATHEROSCLEROSIS | 2016年 / 245卷

关键词：

Commentary; Vitamin D; Hypertension; Coronary heart disease; Risk reclassification; PROTEIN GENE POLYMORPHISMS; VITAMIN-D DEFICIENCY; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; ASSOCIATION; COMMUNITIES; MORTALITY; RACE;

D O I：

10.1016/j.atherosclerosis.2015.11.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：237 / 239

页数：3

共 25 条

[1]

Aloia J., 2015, J CLIN ENDOCR METAB

[2] Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients [J].

Bhan, Ishir ;

Powe, Camille E. ;

Berg, Anders H. ;

Ankers, Elizabeth ;

Wenger, Julia B. ;

Karumanchi, S. Ananth ;

Thadhani, Ravi I. .

KIDNEY INTERNATIONAL, 2012, 82 (01) :84-89

[3] Vitamin D and DBP: The free hormone hypothesis revisited [J].

Chun, Rene F. ;

Peercy, Bradford E. ;

Orwoll, Eric S. ;

Nielson, Carrie M. ;

Adams, John S. ;

Hewison, Martin .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 144 :132-137

[4] Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures [J].

Cook, Nancy R. ;

Ridker, Paul M. .

ANNALS OF INTERNAL MEDICINE, 2009, 150 (11) :795-W143

[5] An Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort [J].

DeFilippis, Andrew P. ;

Young, Rebekah ;

Carrubba, Christopher J. ;

McEvoy, John W. ;

Budoff, Matthew J. ;

Blumenthal, Roger S. ;

Kronmal, Richard A. ;

McClelland, Robyn L. ;

Nasir, Khurram ;

Blaha, Michael J. .

ANNALS OF INTERNAL MEDICINE, 2015, 162 (04) :266-+

[6] Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality [J].

Dobnig, Harald ;

Pilz, Stefan ;

Scharnagl, Hubert ;

Renner, Wilfried ;

Seelhorst, Ursula ;

Wellnitz, Britta ;

Kinkeldei, Jurgen ;

Boehm, Bernhard O. ;

Weihrauch, Gisela ;

Maerz, Winfried .

ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (12) :1340-1349

[7] Plasma 25-hydroxyvitamin D levels and risk of incident hypertension [J].

Forman, John P. ;

Giovannucci, Edward ;

Holmes, Michelle D. ;

Bischoff-Ferrari, Heike A. ;

Tworoger, Shelley S. ;

Willett, Walter C. ;

Curhan, Gary C. .

HYPERTENSION, 2007, 49 (05) :1063-1069

[8] Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D [J].

Johnsen, Martin S. ;

Grimnes, Guri ;

Figenschau, Yngve ;

Torjesen, Peter A. ;

Almas, Bjorg ;

Jorde, Rolf .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (03) :177-183

[9]

LeFevre ML, 2015, ANN INTERN MED, V162, P133, DOI 10.7326/M14-2450

[10]

Li YC, 2002, J CLIN INVEST, V110, P229, DOI [10.1172/JCI200215219, 10.1172/JCI0215219]

← 1 2 3 →